Serial neurophysiological studies of intramuscular botulinum‐A toxin in humans

To characterize the time course of intramuscular botulinum toxin–induced paresis, we serially performed electrophysiological measurements and recorded the sonographic size of an extensor digitorum brevis (EDB) muscle in 10 human subjects before and after injecting the EDB with 10 units of botulinum‐A toxin. All EDB CMAPs decreased within 48 h, with peak decline at day 21 (8.3 ± 3.1 mV to 3.0 ± 0.9 mV). Decline of mean rectified voltage during maximal voluntary contraction of the EDB paralleled the change in CMAP amplitude. Average decrements to 2‐Hz repetitive stimulation never exceeded 6% (day 42) and exercise failed to facilitate Significantly CMAP amplitude. Atrophy peaked at day 42. The F‐wave to M‐wave ratio increased at day 2; silent periods did not change. Our findings confirm a primary peripheral action of the toxin, but a superimposed, transient central effect of the drug cannot be excluded. Intramuscular injections into EDB provide a useful model for studying chemodenervation effects. © 1994 John Wiley & Sons, Inc.

[1]  F. Walker,et al.  Sustained focal effects of low‐dose intramuscular succinylcholine , 1993, Muscle & nerve.

[2]  S. Hashtroudi,et al.  Glycine prodrug facilitates memory retrieval in humans , 1991, Neurology.

[3]  M. Brin,et al.  Laryngeal Dystonia: A Series with Botulinum Toxin Therapy , 1991, The Annals of otology, rhinology, and laryngology.

[4]  B. Wilffert,et al.  Ca2+ influx insensitive to organic Ca2+ entry blockers contributes to noradrenaline-induced contractions of the isolated guinea pig aorta. , 1990, Pharmacology.

[5]  A J Lees,et al.  Botulinum toxin treatment in spasmodic torticollis. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[6]  J. Jankovic,et al.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[7]  K. Setälä,et al.  Long‐term treatment of involuntary facial spasms using botulinum toxin , 1990, Acta ophthalmologica.

[8]  J. Jankovic,et al.  Botulinum toxin injections for cervical dystonia , 1990, Neurology.

[9]  J. Pickett,et al.  AAEE case report #16: Botulism , 1988, Muscle & nerve.

[10]  A. Biglan,et al.  Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum) , 1988, Archives of otolaryngology--head & neck surgery.

[11]  E. Buckley,et al.  Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. , 1988, Ophthalmology.

[12]  Michael J. Aminoff,et al.  Neuromuscular effects distant from the site of botulinum neurotoxin injection , 1988, Neurology.

[13]  M. Hallett,et al.  Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia , 1988, Neurology.

[14]  J. P. Lee,et al.  Botulinum toxin A-induced protective ptosis in corneal disease. , 1988, Ophthalmology.

[15]  J. Elston,et al.  Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. , 1987, The British journal of ophthalmology.

[16]  P. Sweeney,et al.  Benign essential blepharospasm treated with botulinum toxin. , 1987, Cleveland Clinic journal of medicine.

[17]  R. Fross,et al.  Local Treatment of Spasmodic Torticollis with Botulinum Toxin , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  M. Mazow,et al.  Effectiveness of botulinum toxin therapy for essential blepharospasm. , 1987, Ophthalmology.

[19]  J. Fox,et al.  F wave size as a monitor of motor neuron excitability: the effect of deafferentation. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[20]  Madrid,et al.  Electrophysiologic study in benign human botulism type B , 1985, Muscle & nerve.

[21]  S. Seiff,et al.  The use of botulinum toxin in blepharospasm. , 1985, American journal of ophthalmology.

[22]  D. Cornblath,et al.  Clinical electrophysiology of infantile botulism , 1983, Muscle & nerve.

[23]  R. L. Holland,et al.  Nerve growth in botulinum toxin poisoned muscles , 1981, Neuroscience.

[24]  Andrew Eisen,et al.  Amplitude of the F wave , 1979, Neurology.

[25]  B. Shahani,et al.  Assessing segmental excitability after acute rostral lesions , 1978, Neurology.

[26]  Shin J Oh.  Botulism: Electrophysiological studies , 1977, Annals of neurology.

[27]  L. Gutmann,et al.  Pathophysiologic aspects of human botulism. , 1976, Archives of neurology.

[28]  L. Duchen.  An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. , 1971, Journal of the neurological sciences.

[29]  Michael Cherington,et al.  Type B botulism , 1971, Neurology.

[30]  R. F. Mayer,et al.  Observations on the nature of the F wave in man , 1967, Neurology.

[31]  H. R. Tyler,et al.  Physiological Observations in Human Botulism , 1963 .

[32]  J. Elston.  Botulinum toxin therapy for involuntary facial movement , 1988, Eye.

[33]  R. Gonnering.  Treatment of Hemifacial Spasm with Botulinum A Toxin: Results and Rationale , 1986, Ophthalmic plastic and reconstructive surgery.